Sinofn Health
Sinofn Health
In the current global landscape, the nutraceutical industry is undergoing a paradigm shift. Moving beyond simple supplementation, the market now demands precision nutrition, bioavailability optimization, and radical transparency. At SINOFN, we leverage our deep research roots from the Chinese Academy of Sciences to lead this transformation.
The convergence of Big Data and nutraceutical formulation allows for hyper-personalized health interventions. Our R&D team is pioneering the use of AI to predict bioavailability profiles, ensuring that every supplement we manufacture performs with clinical efficacy. Whether it is Phenylketonuria (PKU) management or metabolic health, our data-backed approach minimizes trial-and-error for our partners.
Procuring raw materials and finished goods in the nutraceutical sector requires more than just cost-efficiency—it requires supply chain resilience. SINOFN provides:
Founded in 2012, SINOFN Group represents a intersection of academic rigor and industrial power. Our mission, championed by founder Mrs. GuoHong Liu, is to make specialized nutritional therapies accessible. By bridging the gap between clinical research and commercial manufacturing, we deliver products that are not just safe, but transformational.
Led by Dr. Zhang Ying (CAS Postdoc) and Dr. Tan Shengjie (Peking University Medical), our innovation department focuses on bioactive compound delivery systems and metabolic disorder formulations. With international expertise from Hans van Dijk (Netherlands), we integrate EU regulatory standards into our local manufacturing processes.
Our Tianjin R&D center and Shanghai operations adhere to the highest international standards, including ISO22000, HACCP, FSSC 22000, and HALAL certifications. We don't just meet regulations; we set the benchmark for quality in the nutraceutical space.
We operate a major high-tech facility in China, strategically positioned to support global shipping and logistics, adhering to high-level international geography and service region standards.
Absolutely. We operate pilot-scale prototyping for tablets, capsules, and liquids, allowing brands to test formulations before full-scale commercialization.
Yes. We offer tailored scopes of work, supporting new ventures with low-MOQ capabilities and serving global enterprises with high-volume, automated production lines.
